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Syphilis is a chronic, infectious, sexually transmit-
ted disease caused by Treponema pallidum and can 
affect all tissues and all organs (1). Untreated syphilis 
progresses through four stages: primary, secondary, 
latent and tertiary (1). Among the less common mani-
festations of the secondary stage is syphilitic hepati-
tis; syphilis remains one of the unrecognized etiolo-
gies of liver dysfunction (2). Timely treatment as well 
as effective control of disease are only possible with 
the early diagnosis (3).
A 27-year-old male presented with macular rash 
localized on the trunk and upper extremities, mild 
edema of penile glans, and frequent urination (Fig-
ure 1, Figure 2). The symptoms persisted for several 
months and were treated by his general practice phy-
sician with clotrimazolum and miconazole creams. 
Antihistaminic drugs were prescribed immedi-
ately by dermatologist at once a day over a two week 
period, along with 40% mometazone in Hydrolotio 
cream once a day over a 10 day period for the trunk 
and upper extremities, and alclometasonum cream 
twice a day over 7 days for the genital region pend-
ing further laboratory work up.
Blood tests showed an increased erythrocyte 
sedimentation rate (38 mm/ks), lowered erythrocyte 
count (4.16x1012/L), lowered hemoglobin (126 g/L), 
lowered hematocrite (0-366 L/L), normal white cell 
count with slightly elevated monocyte count (12.8%), 
elevated aspartate aminotransferase level (AST; 121 
U/L), elevated alanine aminotransferase level (ALT; 
200 U/L), elevated gamma-glutamyl transferase level 
(GGT; 182 U/L), elevated C-reactive protein (CRP; 33.7 
mg/L) and normal total immunoglobulin E (IgE; 36 
kIU/L). TPHA was 1:640 and VDRL was reactive. Hepa-
titis B, hepatitis C, and human immunodeficiency vi-
rus serology was negative. Borrelia burgdorferi serol-
ogy was immunoglobulin G (IgG) positive, and immu-
noglobulin M (IgM) negative. Abdominal ultrasound 
showed a normal sized liver with signs of steatosis. 
Blood work for IgG and IgM fluorescent treponema 
antibody-absorption (FTA ABS) was taken before 
therapy. 5 mg of dexamethasonum was administered 
intramuscularly followed by a single dose of 2.4 mil-
lion units of benzatin prenicilin G.
The control examination one month later showed 
a complete regression of all skin and genital chang-
es with normal values of AST, ALT, GGT, AP and CRP 
levels, VDRL 1:32, TPHA 1:2560, IgM FTA ABS nonre-
active, IgG FTA ABS reactive 1:320. Further follow-up 
examinations are planned. 
The first association between hepatitis and syphi-
lis was described in 1943 by Hahn, and since then 
over 100 cases have been described globally (4). In 
2004 Mullick recommended the following criteria in 
establishing syphilitic hepatitis: abnormal levels of 
liver enzyme indicating hepatic involvement, sero-
logical evidence for syphilis with a positive TPHA ti-
ter in conjunction with an acute clinical presentation 
consistent with secondary syphilis, exclusion of alter-
native causes of hepatic injury, and improvements in 
liver enzyme levels with an appropriate antimicrobial 
therapy (5). In our case presented here, all of these cri-
teria were met. Early discovery of reactive TPHA and 
VDRL led to a prompt antibiotic treatment and an ef-
fective conclusion of our patient’s symptoms and 
normalization of the previously unconnected liver 
enzyme dysfunction. Although syphilitic hepatitis is 
a rare manifestation of primary and secondary syphi-
lis, laboratory work up of patients with elevated liver 
enzymes of unknown etiology should include TPHA 
and VDRL measurement to rule out the possibility of 
an underlying syphilis (6).
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